<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f6";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f7";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(7.5 0 0 7.5 37.7952 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">482</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 37.7952 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.677 0.847 1.161 1.499 1.985 2.323 2.682 3.204 3.705 4.225 4.922 5.444 5.966 6.488 6.989" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">Ultrarresúmenes </svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 118.523 787.491) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.235" x="0 1.062 2.149" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)">DAE</svg:tspan></svg:text><svg:text transform="matrix(11 0 0 11 151.402 787.238) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.35 0.865 1.351 1.689 2.175 2.525 2.695 3.181 3.531 4.046 4.405 4.927 5.442 5.928 6.266 6.752 7.186 7.368 7.885 8.407 8.757 9.262 9.784 10.134 10.651 11.166 11.683 12.184 12.366 12.8 12.982 13.499 14.021 14.543" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)"> para la preparación de oposiciones</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.0568 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3486 0.8386 1.2726 1.7066 2.0856 2.5196 2.9536 3.2216 3.4896 3.9236 4.3026 4.5146 4.9486 5.3826 5.8166 6.1956 6.3842 6.8182 7.0302 7.4642 7.8432 8.5002 8.9342 9.2022 9.4142 9.7932 10.2272 10.6062 10.7948 11.2288 11.6628 11.8514 12.1194 12.5534 12.8214 13.4784 13.9124 14.2914 14.7254 15.1044 15.293 15.727 16.161 16.429 16.641 16.909 17.177 17.611 17.879 18.147 18.581 18.96 19.172 19.44 19.874 20.086 20.52 20.899 21.111 21.2996 21.5116 21.9456 22.3246 22.5132 22.8922 23.3262 23.7602 24.1392 24.5732 25.0072 25.2752 25.5432 25.9772 26.3562 26.5682 27.0022 27.4362 27.8702 28.2492 28.4378 28.8718 29.0838 29.5178 29.8968 30.5538 30.9878 31.2558 31.4678 31.8468 32.2808 32.6598 32.8484 33.2824 33.7164 33.905 34.339 34.551 34.985 35.419 35.853 36.287 36.666 36.8546 37.1226 37.5566 37.8246 38.4816 38.9156 39.2946 39.7286 40.1076 40.2962 40.7302 41.1642 41.4322 41.6442 41.9122 42.1802 42.6142 42.8822 43.1502 43.5842 43.9632 44.1752 44.4432 44.8772" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Concentraciones plasmáticas de fármacos antirretrovirales: las concentraciones plasmáticas de algunos fármacos antirretroviral</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 467.846099 756.8378) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.813 1.0016 1.3806 1.8146 2.0032 2.3822 2.8162 3.0842 3.3522 3.7862 3.9982 4.4322" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">es se correla-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196899 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.379 0.591 1.025 1.459 1.893 2.327 2.5099 2.8889 3.3229 3.7569 3.9398 4.3188 4.7528 4.9357 5.3697 5.5867 5.8036 6.1826 6.6166 6.9956 7.2076 7.6416 7.8245 8.2585 8.4414 8.7094 9.1434 9.5224 9.7344 10.1134 10.3254 10.7594 11.1934 11.6274 11.8394 12.0223 12.4563 12.8903 13.1583 13.3412 13.5532 13.9872 14.1701 14.6041 15.0381 15.4721 15.655 16.034 16.468 16.6509 17.0849 17.5189 17.7869 18.2209 18.4889 19.1459 19.3579 19.7919 20.2259 20.6049 20.8169 21.2509 21.6849 21.8678 22.3018 22.7358 23.1698 23.4378 23.6498 24.0838 24.2667 24.6457 25.0797 25.3477 25.5306 25.9646 26.2326 26.4446 26.6566 26.8395 27.2735 27.7075 27.9755 28.4095 28.5924 29.0264 29.4604 29.7284 29.9404 30.5974 30.8094 31.1324 31.5664 31.8344 32.0173 32.3963 32.8303 33.0132 33.4472 33.8262 34.2602 34.4722 34.6551 35.2561 35.6901 35.873 36.252 36.686 36.8689 37.1369 37.5709 37.9499 38.3839 39.0409 39.2529 39.6869 40.1209 40.5549 40.9889 41.1718 41.6058 42.0398 42.3078 42.7418 42.9247 43.3587" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">cionan con su eﬁ cacia o toxicidad, por lo que su determinación podría ser útil para optimizar su uso. No se recomienda para el</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 457.327788 745.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.1829 0.5619 0.9959 1.4299 1.6979 1.9659 2.3999 2.6119 2.7948 3.2288 3.6628 4.0968 4.3088 4.5768 5.0108 5.4448 5.6568 5.8788" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> control habitual, </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196899 734.838199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.868 1.302 1.736 2.17 2.604 2.8165 3.2505 3.6845 4.1185 4.5525 4.9865 5.199 5.633 6.012 6.28 6.714 6.982 7.1945 7.4065 7.8405 8.2745 8.4865 8.8655 9.2995 9.7335 10.1675 10.38 10.814 11.248 11.4605 11.8945 12.1065 12.5405 12.9745 13.4085 13.8425 14.2215 14.434 14.813 15.025 15.293 15.727 16.161 16.54 16.752 17.186 17.62 18.054 18.433 18.6455 19.0245 19.2365 19.4485 19.8825 20.0945 20.4735 20.9075 21.2865 21.499 21.878 22.0905 22.5245 22.9585 23.2265 23.6605 23.873 24.252 24.686 25.12 25.337 25.5495 25.8175 26.4745 26.9085 27.1765 27.389 27.601 28.035 28.2475 28.6265 29.0605 29.4395 29.8735 30.3075 30.6865 31.1205 31.5545 31.767 32.201 32.635 32.8475 33.2815 33.7155 33.928 34.307 34.741 35.398 35.832 36.044 36.256 36.913 37.125 37.559 37.993 38.261 38.695 38.9075 39.1755 39.6095 39.8775 40.3115 40.7455 41.1795 41.6135 41.8815 42.0935 42.4725 42.9065 43.119 43.553 43.987 44.204 44.4165 44.7955 45.0075" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">aunque puede estar indicada en algunas situaciones clínicas y para conﬁ rmar la sospecha de un cumplimiento terapéutico deﬁ cie</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 474.161384 734.838199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.702 1.136" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">nte.</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 56.6929 701.452) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.944 1.5 2.111 2.389 3 3.556 4.056 4.334 4.703 5.259 5.628 6.184 6.795 7.351 7.962 8.351 8.629 9.129 9.685 10.185 10.463 11.074 11.63 11.999 12.555 12.833 13.111 13.667 13.945 14.223 14.834 15.127 15.683 16.183 16.683 16.961 17.572 18.183 18.461 19.072 19.683 20.072 20.225 20.947 21.225" font-family="g_d0_f5" font-size="1px" fill="rgb(255,127,125)">Medidas terapéuticas para la infección por VIH</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 679.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.516 0.905 1.461 1.794 2.35 3.294 3.572 4.128 4.739 5.072 5.683 5.961 6.517 6.795 7.406 7.795 8.351 8.907 9.463 10.074 10.574 10.852 11.463 12.074 12.352 12.963 13.519 13.797 14.075 14.631 15.131 15.409 15.687 16.298 16.631 17.187 17.687 18.187 18.465 19.076 19.687 20.243 20.743 21.021 21.632 22.243 22.854 23.218 23.551 24.162 24.773 25.051 25.551 25.884 26.44 26.94 27.218 27.551 27.829 28.607 28.94 29.218 30.162 30.718 31.218 31.496 31.996 32.607 33.551 34.162 34.773 35.329" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Tratamiento y prevención de las infecciones oportunistas (IO) más comunes</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 657.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 657.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.561 1.783 2.005 2.561 2.783 3.172 3.394 3.838 4.282 4.726 5.17 5.392 5.781 6.003 6.447 6.891 7.335 7.779 8.001 8.445 8.889 9.111 9.555 9.833 10.277 10.721 10.943 11.387 12.054 12.498 12.72 13.387 13.831 14.22 14.442 14.664 15.331 15.775 16.219 16.497 16.775 17.219 17.663 17.941 18.385 18.607 19.051 19.495 19.717 19.939 20.383 20.772 20.994 21.438 21.882 22.271 22.493 22.937 23.381 23.659 24.103 24.492 24.714 24.936 25.38 25.658 26.102 26.491 26.769 27.213 27.657 28.101 28.49 28.712 29.156 29.6 29.878 30.1 30.6 30.822 31.378 31.6" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Las IO siguen siendo un problema muy importante en los pacientes infectados por VIH. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 646.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 646.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.339 1.783 2.227 2.671 2.893 3.171 3.449 3.893 4.171 4.615 4.893 5.282 5.726 5.948 6.392 6.836 7.058 7.336 7.78 8.058 8.725 9.169 9.391 9.835 10.279 10.557 11.001 11.39 11.612 12.001 12.445 12.667 13.056 13.5 13.944 14.166 14.388 14.832 15.221 15.443 15.721 16.165 16.443 17.11 17.554 17.943 18.387 18.776 18.998 19.276 19.72 20.109 20.553 21.22 21.664 22.108 22.552 22.996 23.44 23.884 24.273 24.495 24.717 25.161 25.605 26.049 26.493 26.937 27.381 27.825 28.047 28.491 28.935 29.213 29.657 30.324 30.768 31.212 31.49 31.934 32.156 32.6 33.044 33.266 33.488 33.766 34.044 34.488 34.766 35.21 35.877 36.099 36.543 36.987 37.265 37.709 37.931 38.375 38.819 39.097 39.319 39.597 39.875 40.319 40.597 40.875 41.319 41.708 41.93 42.208 42.652 42.874 43.096" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Deben tratarse de forma agresiva con los fármacos recomendados independientemente del tratamiento antirretroviral. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3391 0.7831 1.1721 1.3772 2.0442 2.4882 2.8772 3.0823 3.3043 3.9713 4.4153 4.8593 5.1373 5.4153 5.8593 6.3033 6.5813 7.0253 7.2304 7.6194 8.0634 8.2685 8.7125 8.9905 9.4345 9.8235 10.2675 10.7115 11.1005 11.3225 11.7665 12.2105 12.4325 12.6376 13.0266 13.4706 13.6757 14.3427 14.7867 15.0087 15.4527 15.7307 15.9358 16.6028 17.0468 17.4908 17.7128 18.1568 18.6008 18.8059 19.2499 19.5279 19.9719 20.3609 20.8049 21.2489 21.5269 21.7489 22.1379 22.5819 22.787 23.231 23.62 23.8251 24.2691 24.4911 24.6962 24.9742 25.2522 25.6962 25.9742 26.4182 27.0852 27.3072 27.7512 28.1952 28.4732 28.9172 29.1223 29.5663 30.0103 30.2883 30.5103 30.7883 31.0663 31.5103 31.7883 32.0663 32.5103 32.8993 33.1213 33.3993 33.8433 34.0653 34.2704 34.7144 35.1584 35.6024 35.8075 36.2515 36.6955 36.9735 37.6405 37.8625 38.1405 38.5845 38.7896 39.2336 39.6776 40.1216 40.3267 40.6047 41.0487 41.4377 41.8817 42.3257 42.7147 42.9927 43.2147 43.4927 43.9367 44.3257 44.5477 44.9917 45.4357 45.6408" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Es muy importante su prevención. La mejor medida preventiva es el tratamiento antirretroviral que permita una reconstitución d</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 476.900084 635.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 0.8711 1.2601 1.4821 1.8711 2.1491 2.5931 3.2601 3.7041" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">el sistema </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 624.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.333 1.777 2.221 2.665 2.887 3.1529 3.5969 4.0409 4.3189 4.7629 5.0288 5.4728 5.9168 6.3058 6.5838 7.0278 7.2937 7.7377 8.1817 8.6257 8.8916 9.3356 9.7246 10.1686 10.4345 10.8785 11.2675 11.7115 11.9895 12.2675 12.7115 12.9774 13.3664 13.6323 14.0213 14.4653 14.7312 15.3982 15.8422 16.2862 16.5642 17.0082 17.4522 17.8962 18.3402 18.6061 19.0501 19.4941 19.7721 20.2161 20.6601 20.9381 21.3821 21.648 22.092 22.536 22.98 23.369 23.6349 24.3019 24.7459 25.1349 25.5789 25.9679 26.1899 26.4558 26.8448 27.2888 27.5547 27.9987 28.4427 28.8317 29.2757 29.6647 29.8867 30.1647 30.6087 30.8867 31.3307 31.7747 32.0406 32.4846 32.7626 33.0406 33.4846 33.8736 34.1395 34.8065 35.2505 35.6945 35.9165 36.3605 36.8045 37.1935 37.4594 37.9034 38.3474 38.6254 39.0694 39.3353 39.7793 40.0013 40.3903 41.0573 41.2793 41.7233 42.1673 42.3893 42.6673 42.9332 43.3772 43.5992 43.8651 44.1431 44.3651 44.8091 45.1981 45.6421 46.0861 46.352 46.796 47.24 47.5059 47.9499" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">inmune; pero hasta que eso ocurra y se mantenga durante unos meses, se necesitarán otras medidas para disminuir el riesgo de es</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 500.237964 624.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.722 1.111" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">tas </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 613.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 0.944 1.388 1.777 2.166 2.388 2.832 3.276 3.72 4.109 4.331" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">infecciones. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 602.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.839 1.283 1.505 1.783 2.227 2.616 3.06 3.727 3.949 4.393 4.837 5.281 5.725 5.947 6.391 6.669 7.113 7.335 7.557 7.779 8.223 8.612 8.834 9.223 9.445 9.889 10.167 10.389 11.056 11.5 11.778 12 12.444 12.666 13.055 13.499 13.943 14.387 14.831 15.275 15.497 15.941 16.163 16.385 16.829 17.051 17.44 17.884 18.106 18.328 18.772 19.216 19.438 19.66 19.882 20.326 20.604 21.048 21.437 21.659 21.937 22.381 22.77 22.992 23.492 24.048 24.492 24.714 25.103 25.547 25.991 26.213 26.657 27.101 27.379 27.601 28.045 28.489 28.933 29.377 29.599 30.043 30.265 30.709 31.153 31.375 31.819 32.263 32.485 32.929 33.373 33.651 34.095 34.373 35.04 35.262 35.706 36.15 36.594 37.038 37.26 37.704 37.926 38.315 38.759 38.981 39.203" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Se recomienda proﬁ laxis primaria cuando el nivel de linfocitos CD4 cae por debajo de un determinado nivel. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.895 1.117 1.561 2.005 2.449 2.893 3.282 3.562 3.784 4.34 4.62 4.898 5.12 5.564 6.008 6.452 6.896 7.34 7.62 8.064 8.344 8.622 9.066 9.455 9.677 10.121 10.343 10.732 11.176 11.384 11.606 11.886 12.33 12.774 13.218 13.498 13.887 14.331 14.664 14.944 15.222 15.5 15.944 16.222 16.666 17.11 17.554 17.943 18.165 18.445 18.834 19.056 19.336 19.558 20.002 20.282 20.671 20.893 21.171 21.615 22.059 22.448 22.67 23.114 23.558 23.838 24.06 24.504 25.171 25.615 26.059 26.503 26.725 27.169 27.613 27.835 28.224 28.668 28.948 29.392 29.836 30.116 30.56 31.004 31.284 31.951 32.395 32.617 33.061 33.339 33.783 34.227 34.671 34.893 35.173 35.562 36.006 36.286 36.564 37.008 37.397 37.841 38.508 38.73 39.174 39.618 40.062 40.506 40.786 41.23 41.674 41.954 42.398 42.787 43.065 43.509 43.898 44.178 44.567 45.011 45.4 45.844 46.233 46.513 46.957" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Algunas IO tienden a recidivar, una vez tratadas, si la situación inmunológica no ha mejorado; se recomienda en estos casos pr</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 487.250991 591.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 0.888 1.11 1.554 1.943 2.165 2.554" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">oﬁ laxis </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196879 580.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.666 2.11 2.554 2.998 3.276 3.498 3.942 4.164 4.608 4.83 5.108 5.386 5.83 6.108 6.552 7.219 7.441 7.885 8.329 8.607 9.051 9.273 9.662 10.106 10.55 10.828 11.272 11.661 12.105 12.313" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">secundaria o tratamiento supresor.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 558.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.516 0.905 1.461 1.794 2.35 3.294 3.572 4.128 4.739 5.072 5.683 5.961 6.517 7.128 7.461 7.739 8.103 8.492 9.048 9.381 9.77 10.366 10.922 11.2 11.589 12.145 12.423 12.701 13.034 13.57 14.292 14.959" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">Tratamiento antirretroviral (TAR)</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 536.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 536.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.728 1.172 1.561 1.783 2.45 2.894 3.172 3.394 3.783 4.227 4.616 4.838 5.282 5.726 6.004 6.448 6.67 6.892 7.336 7.558 7.947 8.169 8.613 8.891 9.113 9.557 9.779 10.001 10.395 10.951 11.451 11.673 12.062 12.506 12.95" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Los motivos para iniciar el TAR son:</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 525.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.777 3.166 3.555 3.777 4.221 4.665 4.887 5.331 5.775 5.997 6.219 6.663 6.885 7.552 7.996 8.274 8.718 8.94 9.607 10.051 10.329 10.607 11.051 11.273 11.495 11.939 12.383 12.827 13.049 13.493 13.882 14.326 14.715 14.937 15.381 15.825 16.269 16.491 16.935 17.157 17.379 17.823 18.045 18.267 18.711 18.989 19.433 19.822 20.211 20.433 20.877 21.321 21.543 21.987 22.431 22.709 22.931 23.431 23.653 24.209" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Reducción de la morbimortalidad asociada a la infección por VIH.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 514.8384) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.278 2.722 3.166 3.61 3.888 4.332 4.721 4.943 5.387 5.831 6.053 6.442 6.664 7.108 7.386 7.83 8.219 8.663 8.941 9.33 9.774 10.163 10.385 10.829 11.273 11.495 11.939 12.383 12.605 12.827 13.271 13.493 13.771 14.215 14.659 15.048 15.27 15.714 16.158 16.38 16.602 17.046 17.713 18.157 18.601 19.045 19.267 19.711 20.155 20.377 20.766 21.21" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Recuperación y preservación de la función inmunológica.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 503.8386) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.778 2 2.278 2.722 3 3.222 3.666 3.888 4.11 4.554 4.832 5.276 5.665 5.943 6.387 6.609 7.053 7.497 7.886 8.108 8.497 8.941 9.163 9.607 10.051 10.273 10.495 10.939 11.161 11.439 11.883 12.327 12.549 12.771 13.16 13.604 13.993 14.215 14.659 15.103 15.325 15.769 16.213 16.435 16.657 17.157 17.379 17.935 18.157 18.546 18.99 19.434 19.712 20.156 20.378 20.767 21.211 21.878 22.322 22.6 23.044 23.266 23.488 23.71 24.154 24.598 25.042 25.486 25.875 26.097 26.541 26.93 27.152 27.541 27.819 28.263 28.707 28.985 29.429 29.818" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Evitar el efecto nocivo de la replicación del VIH sobre comorbilidades existentes.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.1969 492.8388) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.944 3.388 3.777 3.999 4.443 4.887 5.109 5.553 5.997 6.219 6.441 6.885 7.107 7.385 7.663 8.107 8.551 8.94 9.607 9.829 10.218 10.44 10.884 11.328 11.55 11.994 12.438 12.66 12.882 13.382 13.604 14.16 14.382" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">- Prevención de la transmisión del VIH. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 470.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 470.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3384 0.8014 1.2454 1.4674 1.9114 2.1894 2.6334 2.9114 3.1238 3.5678 4.0118 4.2242 4.5022 4.9462 5.2242 5.8912 6.3352 6.5476 6.7696 7.2136 7.6576 7.8796 8.2686 8.4906 8.9346 9.3786 9.8226 10.0446 10.257 10.701 10.923 11.1354 11.8024 12.2464 12.9134 13.3574 13.8014 14.0794 14.5234 14.7358 15.1798 15.6238 15.8362 16.0582 16.5022 16.7242 17.1132 17.3352 17.7792 17.9916 18.4356 18.8796 19.1016 19.314 19.708 20.264 20.764 20.9764 21.3654 21.5778 21.7998 22.2438 22.6328 22.8452 23.1232 23.5672 23.8452 24.5122 24.9562 25.3452 25.7892 26.1782 26.3906 26.8346 27.2786 27.7226 27.935 28.379 28.823 29.267 29.711 30.155 30.3674 30.6454 31.0894 31.3674 32.0344 32.4784 32.7564 32.9688 33.4128 33.8568 34.1348 34.4128 34.8568 35.0692 35.5132 35.9572 36.1792 36.3916 36.6696 37.1136 37.5576 37.7796 38.4466 38.8906 39.3346 39.547 39.769 40.213 40.435 40.824 41.046 41.49 41.712 41.934 42.1464 42.5354 42.9794 43.4234 43.8674 44.2564 44.7004 45.1444 45.5884 46.0324" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Valorar de forma individual el momento de inicio del TAR y los fármacos que deben formar parte del régimen inicial, sopesando </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 478.338298 470.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.2674 1.6564 2.1004 2.5444 2.8224 3.2664" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">las venta-</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196914 459.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.277 1.721 1.943 2.165 2.609 2.998 3.442 3.886 4.275 4.719 5.163 5.385 5.829 6.273 6.551 6.995 7.384 7.606 7.828 8.217 8.661 8.883 9.327 9.549 9.938 10.382 10.826 11.215 11.437 11.826 12.048 12.492 12.936 13.158 13.547 13.769 13.991 14.435 14.657 15.324 15.768 16.046 16.268 16.657 17.101 17.49 17.712 18.156 18.6 18.822 19.266 19.71 19.932 20.154 20.598 21.042 21.431 21.653 22.097 22.541 22.819 23.263 23.485 23.929 24.318 24.54 24.984 25.428 25.65 25.928 26.372 26.761 27.039 27.483 27.761 27.983 28.372 28.65 28.872 29.15 29.372 29.761 30.205 30.427 30.871 31.093 31.315 31.759 31.981 32.425 32.869 33.147 33.591 33.813 34.257 34.701 34.923 35.201 35.645 36.312 36.756 37.034 37.256 37.478 37.922 38.144 38.588 39.032 39.421 39.643 40.032 40.254 40.698 41.142 41.364 41.808 42.252 42.474 42.863 43.307 43.751 44.195 44.639" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">jas e inconvenientes. La disposición y la motivación del paciente es un factor crítico a la hora de tomar la decisión de cuándo</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 470.92953 459.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.333 1.777 2.221 2.554 2.998 3.276 3.498 3.942" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> empezarlo.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 56.6929 448.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f4" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 62.1468 448.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3392 0.8952 1.2842 1.5622 2.0062 2.4502 2.6722 3.3392 3.7832 4.2272 4.5052 4.9492 5.1814 5.5704 6.0144 6.2466 6.6906 6.9126 7.3016 7.7456 8.1896 8.6336 9.0776 9.3098 9.7538 10.1978 10.43 10.874 11.263 11.707 12.151 12.595 13.039 13.2712 13.7152 14.1592" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)"> Actualmente se dispone en España de </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 191.661301 448.802) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.439 0.934 1.151 1.59 1.8172 2.0902 2.5852 3.3022 3.5192 3.7362 3.9532 4.4482 4.8872 5.1144 5.6094 6.1044 6.3316 6.6046 7.0996 7.4276 8.1446 8.6396 9.1346 9.6296 10.0686 10.2958 10.7908 11.2858 11.5588 11.7758 12.1038 12.4318 12.9268 13.1998 13.5278 14.0228 14.4618 14.6788 15.0068 15.5018 15.7188 16.2138" font-family="g_d0_f6" font-size="1px" fill="rgb(43,46,52)">seis familias de fármacos antirretrovirales</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 341.532 448.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.4542 0.8982 1.3422 1.7862 2.0184 2.4074 2.8514 3.2954 3.7394 4.1834 4.6274 5.0714 5.3036 5.7476 6.1916 6.4238 6.7018 7.1458 7.4238 7.8678 8.0898 8.322 8.766 9.21 9.4422 9.7202 10.1642 10.4422 11.1092 11.5532 11.9422 12.3862 12.7752 12.9972 13.2294 13.7294 14.1734 14.4056 14.8496 15.2936 15.5716 16.0156 16.4596 16.9036 17.3476 17.5798 18.0238 18.4678 18.7458" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">, que suponen en total 24 fármacos. Se agrupan por </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 65.196905 437.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.722 2.166 2.555 2.999 3.443 3.665 4.054 4.721 5.165 5.387 5.831 6.275 6.497 6.941 7.33 7.719 7.941 8.385 8.829 9.051 9.273 9.773 10.217 10.439 10.717 11.161 11.55 11.994 12.661 12.883 13.327 13.771 14.215 14.659 14.881 15.325 15.769 16.213 16.435 16.879 17.101 17.323 17.601 17.879 18.323 18.601 19.045 19.712 19.934 20.378 20.822 21.1 21.544 21.766 22.155 22.599 22.821 23.265 23.709 24.153 24.597 24.819 25.208 25.43 25.874 26.541 26.985 27.263 27.707 27.929 28.318 28.762 29.206 29.428 29.872 30.316 30.76 30.982 31.371 31.815 32.482 32.926 33.148 33.592 34.036 34.425 34.647 35.091 35.535 35.757 36.201 36.645 36.867 37.145 37.589 37.867 38.534 38.978 39.367 39.811 40.2 40.422 40.644 41.088 41.532 41.976 42.198 42.476 42.92 43.364 43.586 44.253 44.697 45.141 45.419 45.863 46.085 46.363 46.641 47.085 47.474" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">su mecanismo de acción. Se recomienda que el tratamiento se haga siempre con una combinación de fármacos, habitualmente tres.</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 71.4458 413.029) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.569 1.081 1.443 2.168 2.68 3.119 3.663 4.203 4.582 5.094 5.642 5.98 6.196 6.558 6.912 7.46 7.798 8.152 8.696 9.193 9.409 9.747 10.259 10.471 11.019 11.559 11.938 12.485 12.823 13.039 13.251 13.467 13.928 14.44 14.969 15.513 16.053 16.432 16.98 17.528 17.907 18.119 18.631 19.01 19.522 19.961 20.299 20.846 21.358 21.57 21.786 22.315 22.827 23.356" font-family="g_d0_f7" font-size="1px" fill="rgb(64,198,192)">Fármacos antirretrovirales utilizados en la actualidad </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 393.8725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.444 0.944 1.666 1.888 2.11 2.332" font-family="g_d0_f6" font-size="1px" fill="rgb(64,198,192)">Familia</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669 393.8725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.444 0.944 1.277 1.999 2.499 2.999 3.499" font-family="g_d0_f6" font-size="1px" fill="rgb(64,198,192)">Fármacos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063 393.8725) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 1.056 1.778 2.278 2.778 3.056 3.556 3.889 4.111" font-family="g_d0_f6" font-size="1px" fill="rgb(64,198,192)">Comentario</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 340.6115) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 1.998 2.442 2.886 3.164 3.608 3.997 4.219 4.663 5.107 5.329 5.551 5.995 6.217 6.495 6.773 7.217 7.661 8.05 8.439 8.717 8.939 9.383 9.661 10.105 10.494 10.938" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Inhibidores de la transcriptasa </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 330.61125) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.499 1.777 2.166 2.61 2.832 3.276 3.72 4.164 4.386 4.83 5.274 5.718 6.107 6.329 6.773 7.217 7.439 7.661 8.105 8.494 8.716 9.16 9.604 9.993 10.215 10.659 11.103 11.492 11.714 12.158 12.602 12.991" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">inversa análogos de los nucleósidos </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 320.611) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.444 0.888 1.11 1.666 2.277" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">(ITIAN)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 300.410751) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.722 1.166 1.388 1.61 2.054 2.443 2.665 3.109 3.498 3.942 4.164 4.442 4.886 5.33 5.774 6.052 6.496 6.885 7.107 7.385 7.607 8.051 8.495 8.939 9.383 9.827 10.271 10.493 10.937 11.326" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">(Se incluye tenofovir aunque es </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 290.210751) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.554 1.998 2.442 2.886 3.108 3.552 3.996 4.218 4.44 4.884 5.273 5.495 5.939 6.383 6.772 6.994 7.438 7.882 8.16 8.382 8.826 9.27 9.659" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">análogo de los nucleótidos)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 374.35055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.444 1.833 2.277 2.666 2.888 3.166 3.388 3.61 4.166 4.666 5.166 11.811 12.2 12.644 13.088 13.366 13.81 14.254 14.476 14.698 15.142 15.531 15.753 16.197 16.475 16.697 17.364 17.808 18.086 18.53 18.919 19.141 19.419 19.863 20.141 20.808 21.252 21.641 22.085 22.474 22.696 23.14 23.418 23.64 23.862 24.084 24.417 24.861 25.305 25.749 26.138 26.36 26.749 26.971 27.36 27.582 28.026 28.47 28.914 29.358 29.58 29.969 30.191 30.635 31.079 31.523 31.967 32.189 32.411 32.855 33.077 33.521 33.965 34.354 34.798 35.02 35.464 35.908 36.13 36.352 36.796" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Abacavir (ABC)Fueron los primeros fármacos utilizados y siguen siendo la base de la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 364.15055) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 1.111 1.5 1.944 2.222 2.444 2.888 3.11 3.554 3.998 4.22 4.442 4.886 5.275 5.497 5.775 6.219 6.663 6.885 7.552 7.996 8.44 8.884" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">mayoría de los regímenes</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 342.612399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.444 1.833 2.277 2.944 3.388 3.61 4.054 4.498 4.887 5.109 5.553 5.997 6.441 6.83 7.052 7.496 7.94 8.162 8.384 8.828 9.05 9.606 10.217 10.439 10.883 11.327 11.549 11.993 12.215 12.659 13.048 13.437 13.659 14.103 14.547 14.769 15.213 15.657 15.935 16.379 16.601 16.879 17.323 17.767 17.989 18.656 19.1 19.544 19.988 20.377 20.599 21.043 21.487 21.709 21.931 22.375 22.597 22.986 23.208 23.652 23.874 24.263 24.707 25.151" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Las combinaciones de ITIAN de elección para regímenes de inicio son </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 332.412399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 1 1.389 1.722 2.111 2.555 3.055 3.277 3.721 3.943 4.499 4.999 5.499 5.832 6.276 6.72 7.22 7.442 7.664 8.164 8.608 8.83 9.108 9.552 9.941 10.385 11.052 11.274 11.718 12.162 12.606 13.05 13.272 13.661 14.105 14.327 14.771 15.16 15.604 15.826 16.27 16.714 16.936 17.325 17.769 18.047 18.491 18.769 19.436 19.88 20.102 20.546 20.935 21.157 21.601 22.045 22.489 22.878" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">TDF/FTC o ABC/3TC. Se recomienda su uso en coformulaciones </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 310.8734) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.444 1.888 2.555 2.999 3.221 3.665 4.109 4.498 4.72 5.164 5.608 5.83 6.274 6.83 7.219 7.552 7.941 8.385 8.885 9.107 9.551 9.995 10.439 10.883 11.105 11.549 11.827 12.049 12.271 12.493 12.826 13.27 13.548 13.937 14.381 14.603 14.992 15.436 15.88 16.102 16.546 16.824 17.268 17.657 18.101 18.545 18.934 19.156 19.6 20.044 20.266 20.71 21.154 21.376 21.82 22.264 22.653 22.875 23.319 23.763 24.041 24.485 24.874" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">La combinación TDF/FTC debe utilizarse con precaución en pacientes </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 300.673399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.499 1.721 2.165 2.554 2.998 3.22 3.442 3.831 4.053 4.497 4.941 5.33 5.552 5.996 6.218 6.496 6.94 7.384 7.828 8.05" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">con insuﬁ ciencia renal </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 279.1344) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.444 1.888 2.555 2.999 3.221 3.665 4.109 4.498 4.72 5.164 5.608 5.83 6.386 6.886 7.386 7.719 8.163 8.607 9.107 9.329 9.773 10.217 10.661 11.105 11.327 11.716 12.16 12.438 12.66 13.104 13.771 14.215 14.437 14.881 15.325 15.769 16.213 16.435 16.824 17.268 17.712 17.934 18.378 18.656 19.1 19.489 19.933 20.377 20.766 20.988 21.432 21.876 22.098 22.542 22.986" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">La combinación ABC/3TC debe ser empleada con precaución en </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 268.9344) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.387 2.665 3.109 3.498 3.72 4.109 4.553 4.997 5.219 5.719 6.219 6.663 6.885 7.329 7.551 7.995 8.384 8.828 9.272 9.716 9.938 10.16 10.827 11.271 11.66 11.882 12.326 12.77 12.992 13.436 13.88 14.324 14.546 14.99 15.434 15.878 16.1 16.489 16.933 17.377 17.599 18.043 18.432 18.765 19.432 19.821 20.043 20.265 20.654 21.098 21.542 21.986 22.43 22.874 23.096 23.485 23.929" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">pacientes con CVP elevada (más de 100.000 copias/mL) cuando se </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 258.7344) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.5 1.944 2.166 2.61 3.054 3.276 3.665 4.109 4.553 4.775 5.219 5.663 5.885 6.107 6.551 6.773 7.384 7.995 8.217 8.661 8.883 9.327 9.771 9.993 10.215 10.659 10.992 11.27 11.492 11.936 12.158 12.547 12.825 13.047 13.491 13.769 14.213 14.435 14.879 15.323 15.545 15.934 16.378 16.878 17.211" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">combina con un ITINN o un IP/r distinto de LPV/r</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 354.744446) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.778 1.222 1.666 2.11 2.554 2.943 3.165 3.609 4.053 4.275 4.497 4.941 5.385 5.607" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Didanosina (ddI)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 335.138345) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 1.111 1.389 1.667 1.889 2.278 2.5 2.778 3.222 3.666 3.888 4.332 4.776 4.998 5.22 5.609 6.053 6.553" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Emtricitabina (FTC)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 315.531395) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.111 1.555 1.944 2.388 2.832 3.054 3.498 3.942 4.164 4.386 4.83 5.274 5.718" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Estavudina (d4T)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 298.287444) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.5 1.722 2.111 2.555 2.999 3.221 3.665 4.109 4.331 4.553 4.997 5.441 5.941" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Lamivudina (3TC)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 278.681343) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.11 1.554 1.943 2.387 2.831 3.053 3.497 3.941 4.163 4.385 4.941 5.385 5.829" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Zidovudina (AZT)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 259.074393) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.37 0.814 1.258 1.702 1.98 2.424 2.813 3.035 3.313 3.535 3.757 4.201 4.757 5.146" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Tenofovir (TDF)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 173.12919) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 1.998 2.442 2.886 3.164 3.608 3.997 4.219 4.663 5.107 5.329 5.551 5.995 6.217 6.495 6.773 7.217 7.661 8.05 8.439 8.717 8.939 9.383 9.661 10.105 10.494 10.938" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Inhibidores de la transcriptasa </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 162.92919) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.055 1.499 1.777 2.166 2.61 2.832 3.276 3.72 3.942 4.386 4.83 5.274 5.496 5.94 6.384 6.828 7.217 7.439 7.883 8.327 8.549 8.771 9.215 9.604" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">inversa no análogos de los </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 60.6929 152.72919) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.387 2.776 2.998 3.442 3.886 4.275 4.497 4.719 4.941 5.385 5.607 6.218 6.829" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">nucleósidos (ITINN)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 229.259791) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1.166 1.555 1.777 2.055 2.499 2.943 3.276 3.498 3.72 4.164 4.553 5.053" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Efavirenz (EFV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 241.736091) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.444 1.888 2.555 2.999 3.221 3.665 4.109 4.498 4.72 5.164 5.608 5.83 6.274 6.718 6.94 7.384 7.773 8.273 8.606 9.05 9.606 9.995 10.328 10.717 11.161 11.661 11.883 12.272 12.716 12.938 13.327 13.771 14.215 14.604 14.826 15.27 15.714 15.992 16.436 16.658 17.102 17.546 17.99 18.212 18.656 19.1 19.489 19.711 20.155 20.599 20.821 21.265 21.543 21.987 22.265 22.709 22.987 23.431 23.875 24.153 24.597 24.819 25.263 25.707" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">La combinación de EFV/TDF/FTC se considera una opción preferente de </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 231.536091) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.556 1 1.278 1.722 2.389 2.611 3.055 3.499 3.777" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">tratamiento</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 215.667441) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.444 1.888 2.555 2.999 3.221 3.665 4.109 4.498 4.72 5.164 5.608 5.83 6.274 6.718 6.94 7.384 7.773 8.273 8.495 8.939 9.161 9.717 10.217 10.717 11.05 11.494 11.938 12.438 12.66 13.104 13.548 13.992 14.436 14.658 15.102 15.491 15.713 15.991 16.435 16.713 17.102 17.546 17.768 18.212 18.656 18.878 19.322 19.766 20.155 20.377 20.821 21.265 21.543 21.987 22.376 22.598 22.987 23.431 23.875 24.097 24.597 25.097 25.541" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">La combinación de EFV + ABC/3TC debe evitarse en pacientes con CVP </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 205.467441) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.667 1.111 1.5 1.944 2.222 2.444 2.888 3.332 3.554 3.998 4.442 4.886 5.108 5.552 5.996 6.44 6.662 7.051 7.495 7.939 8.161 8.605 8.994 9.327 9.994" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">mayor de 100.000 copias/ml</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 189.597091) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.333 1.555 1.999 2.388 2.666 3.11 3.332 3.721 4.165 4.609 4.887 5.165 5.609 5.831 6.275 6.719 6.941 7.33 7.774 8.218 8.662 8.884 9.328 9.772 10.05 10.494 10.938 11.216 11.66 11.882 12.326 12.548 12.77 13.214 13.492 13.714 14.381 14.825 15.103 15.325 15.603 15.881 16.103 16.77 17.214 17.603 17.881 18.159 18.603 18.825 19.269 19.713 19.935 20.157 20.601 20.823 21.267 21.711 22.1 22.378 22.822 23.211 23.433 23.877 24.321 24.543" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">EFV está contraindicado durante el primer trimestre de la gestación. </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 179.39709) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.945 1.167 1.834 2.056 2.445 3.112 3.556 3.778 4 4.389 4.833 5.055 5.499 5.943 6.387 6.831 7.053 7.497 7.886 8.108 8.386 8.83 9.108 9.33 9.774 10.218 10.44 10.884 11.328 11.717 11.939 12.383 12.827 13.105 13.549 13.938 14.16 14.604 15.048 15.492 15.714 15.992 16.436 16.88 17.102 17.324 17.713 18.157 18.601 18.823 19.101 19.545 19.823 20.267 20.711 21.1 21.322 21.766 22.21 22.432 22.654 23.098 23.376 23.82 24.209 24.653 25.042" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Asimismo, se debe evitar en pacientes que realicen tareas peligrosas </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 169.19709) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.611 0.833 1.277 1.555 1.999 2.388 2.832 3.276 3.554 3.998 4.442 4.664 5.053 5.275 5.719 5.997 6.441 7.108 7.552 7.941 8.163 8.607 9.051 9.273 9.662 10.106 10.773 11.217 11.661 11.883 12.327 12.771 13.16 13.382 13.826 14.048 14.27 14.937 15.381 15.659 16.103 16.547 16.936 17.158 17.547 17.88 18.324 18.546 18.824 19.102 19.546 19.935 20.213 20.657 20.935 21.379 21.823 22.212 22.434 22.878 23.322 23.544 23.766 24.21" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">si presentan síntomas de somnolencia, mareos y/o trastornos de la </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 158.99709) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.666 2.11 2.554 2.832 3.11 3.554 3.943 4.165 4.609" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">concentración</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 143.12844) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.111 1.555 1.777 2.166 2.61 3.054 3.332 3.61 4.054 4.276 4.72 5.164 5.386 5.775 6.219 6.663 7.107 7.329 7.773 7.995 8.217 8.661 9.05 9.494 9.716 10.16 10.604 10.826 11.437 11.937 12.381 12.603 13.047 13.491 13.713 14.38 14.824 15.046 15.49 15.768 16.212 16.601 16.823 17.212 17.656 18.1 18.322 18.711 18.933 19.211 19.489 19.933 20.322 20.544 20.988 21.432 21.654 21.876 22.098 22.542 22.82 23.264 23.653 23.875 24.153 24.597 24.986" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Está contraindicado el uso de NVP en mujeres con cifras de linfocitos </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 132.92844) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 1.056 1.5 1.722 2.166 2.388 2.777 3.221 3.665 4.109 4.387 4.609 5.053 5.331 5.775 6.164 6.386 6.83 7.052 7.496 7.94 8.384 8.606 8.995 9.439 9.661 10.105 10.327 10.771 11.16 11.493 11.937 12.326 12.548 12.937 13.159 13.603 14.047 14.269 14.658 15.102 15.38 15.824 16.268 16.712 17.101 17.323 17.712 18.156 18.6 18.822 19.211 19.433 19.711 19.989 20.433 20.822 21.044 21.433 21.877 22.321 22.765 23.043 23.265 23.709 23.987 24.431 24.82 25.042 25.486" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">CD4 + superiores a 250 células/µL y en varones con cifras superiores a </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 122.72844) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.554 1.943 2.387 2.609 3.053 3.275 3.719 4.108 4.441 4.885" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">400 células/µL</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 106.85979) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 0.888 1.388 1.832 2.332 2.554 2.998 3.442 3.664 4.108 4.552 4.996 5.44 5.662 6.106 6.384 6.606 6.828 7.05 7.383 7.827 8.105 8.494 8.938 9.16 9.604 10.048 10.27 10.714 11.158 11.547 11.769 12.213 12.657 12.935 13.379 13.768 13.99 14.379 14.823 15.267 15.489 15.989 16.489 16.933 17.155 17.822 18.266 18.655 19.099 19.377 19.599 20.043 20.487 20.709 21.153 21.597 22.041 22.263 22.707 23.151 23.595" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">El RPV no debe utilizarse en pacientes con CVP mayor de 100.000 </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 96.65979) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.499 1.943 2.332 2.665 3.332 3.721 3.943 4.165 4.609 5.053 5.275 5.719 6.163 6.552 6.774 7.218 7.662 7.94 8.384 8.773 8.995 9.384 9.828 10.272 10.494 10.994 11.494 11.938 12.16 12.382 12.826 13.104 13.548 13.826 14.048 14.492 14.77 14.992 15.436 15.658 16.102 16.546 16.99 17.212 17.656 18.1 18.544 18.766 18.988 19.432 19.654 20.043 20.487 21.154 21.598 21.82 22.264 22.708 23.097 23.319 23.763 24.207" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">copias/mL. En pacientes con CVP inferior a 100.000 la combinación </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 282.063501 86.45979) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.444 1.777 2.221 2.777 3.166 3.499 3.888 4.332 4.832 5.054 5.443 5.887 6.109 6.498 6.942 7.386 7.775 7.997 8.441 8.885 9.163 9.607 9.829 10.273 10.717 11.161 11.383 11.827 12.271 12.66 12.882 13.326 13.77 13.992 14.436 14.714 15.158 15.436 15.88 16.158 16.602 17.046 17.324 17.768 17.99 18.434 18.878 19.1 19.378 19.656 20.1 20.378 20.822 21.489 21.711 22.155 22.599 22.877" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">RPV/TDF/FTC se considera una opción preferente de tratamiento</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 189.57584) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.611 1.055 1.444 1.666 1.944 2.388 2.832 3.054 3.498 3.942 4.164 4.386 4.997 5.497 5.941" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Nevirapina (NVP)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 149.891041) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.722 1 1.444 1.833 2.055 2.333 2.555 2.999 3.443 3.665 3.887 4.331 4.775 5.275" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Etravirina (ETR)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 181.669151 103.40284) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 0.944 1.388 1.61 1.999 2.221 2.499 2.721 3.165 3.609 3.831 4.053 4.553 4.997 5.497" font-family="g_d0_f4" font-size="1px" fill="rgb(43,46,52)">Rilpivirina (RPV)</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>